Genetically predicted blood metabolites mediate the association between circulating immune cells and severe COVID-19: A Mendelian randomization study

Ning Ai,Yan Zhang,Jing Yang,Yu Zhang,Xuejing Zhao,Huifen Feng
DOI: https://doi.org/10.1097/md.0000000000040509
IF: 1.6
2024-11-28
Medicine
Abstract:COVID-19 is an acute respiratory infectious disease caused by SARS-CoV-2 infection, which is highly contagious and characterized by high morbidity and mortality. The majority of individuals with COVID-19 exhibit mild to moderate symptoms, and some even present with asymptomatic infections, but 10% to 20% develop severe symptoms of systemic inflammation and tissue damage, acute respiratory distress syndrome, respiratory failure, coagulation, shock, and multiple organ dysfunction. [ 1–5 ] As of October 2022, COVID-19 had resulted in over 6.5 million fatalities out of 620 million confirmed cases, posing an enormous threat to the global economy and public health. [ 6 ] SARS-CoV-2 expresses 4 structural proteins: spike, nucleocapsid, membrane, and envelope. The spike protein mediates viral entry into cells via its interaction with angiotensin-converting enzyme 2, thereby initiating subsequent replication and transcription processes essential for infection. [ 7 ]
medicine, general & internal
What problem does this paper attempt to address?